Biglycan promotes the chemotherapy resistance of colon cancer by activating NF-κB signal transduction
出版年份 2018 全文链接
标题
Biglycan promotes the chemotherapy resistance of colon cancer by activating NF-κB signal transduction
作者
关键词
Apoptosis, Biglycan, Multiple drug resistance, Colon cancer, NF-κB
出版物
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2018-05-14
DOI
10.1007/s11010-018-3365-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Evodiamine Suppresses ABCG2 Mediated Drug Resistance by Inhibiting p50/p65 NF-κB Pathway in Colorectal Cancer
- (2016) Hua Sui et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Chronic Inflammation and Colorectal Cancer: The Role of Vascular Endothelial Growth Factor
- (2015) Tao Hu et al. CURRENT PHARMACEUTICAL DESIGN
- Knockdown of biglycan expression by RNA interference inhibits the proliferation and invasion of, and induces apoptosis in, the HCT116 colon cancer cell line
- (2015) XIAOJING XING et al. Molecular Medicine Reports
- Soluble biglycan induces the production of ICAM-1 and MCP-1 in human aortic valve interstitial cells through TLR2/4 and the ERK1/2 pathway
- (2014) Rui Song et al. INFLAMMATION RESEARCH
- Cigarette smoking and gastrointestinal diseases: The causal relationship and underlying molecular mechanisms (Review)
- (2014) L.F. LI et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Biglycan up-regulated vascular endothelial growth factor (VEGF) expression and promoted angiogenesis in colon cancer
- (2014) Xiaojing Xing et al. TUMOR BIOLOGY
- Biglycan Induces the Expression of Osteogenic Factors in Human Aortic Valve Interstitial Cells via Toll-Like Receptor-2
- (2012) Rui Song et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells
- (2012) K Yamamoto et al. BRITISH JOURNAL OF CANCER
- The HumanTLRInnate Immune Gene Family Is Differentially Influenced by DNA Stress andp53Status in Cancer Cells
- (2012) Maria Shatz et al. CANCER RESEARCH
- Expansion of CD133+ colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery
- (2010) D D Fang et al. BRITISH JOURNAL OF CANCER
- Targeting NF-κB for colorectal cancer
- (2010) Kei Sakamoto et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The extracellular matrix at a glance
- (2010) C. Frantz et al. JOURNAL OF CELL SCIENCE
- Colorectal cancer
- (2010) David Cunningham et al. LANCET
- CD133 expression predicts for non-response to chemotherapy in colorectal cancer
- (2010) Chee W Ong et al. MODERN PATHOLOGY
- Chemoresistant Colorectal Cancer Cells, the Cancer Stem Cell Phenotype, and Increased Sensitivity to Insulin-like Growth Factor-I Receptor Inhibition
- (2009) N. A. Dallas et al. CANCER RESEARCH
- Biglycan, a Danger Signal That Activates the NLRP3 Inflammasome via Toll-like and P2X Receptors
- (2009) Andrea Babelova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Looking ahead in cancer stem cell research
- (2009) John E Dick NATURE BIOTECHNOLOGY
- Quantitative Proteomics Analysis Integrated with Microarray Data Reveals That Extracellular Matrix Proteins, Catenins, and P53 Binding Protein 1 Are Important for Chemotherapy Response in Ovarian Cancers
- (2009) Sheng Pan et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Biglycan Is Required for Adaptive Remodeling After Myocardial Infarction
- (2008) D. Westermann et al. CIRCULATION
- A phase Ib dose-escalation study of erlotinib, capecitabine and oxaliplatin in metastatic colorectal cancer patients
- (2007) E. Van Cutsem et al. ANNALS OF ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started